A Novel Scoring System to Predict Acute Radiation Enteritis Recovery in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy: A Southwest China Cohort Study
Chuan Zeng,Jia Ji,Yusheng Huang,Yuan Peng,Xiaoyue Zhang,Zhenzhou Yang,Zhengjun Guo
DOI: https://doi.org/10.2147/ijgm.s485087
IF: 2.145
2024-12-10
International Journal of General Medicine
Abstract:Chuan Zeng, 1, 2 Jia Ji, 3 Yusheng Huang, 1, 2 Yuan Peng, 1, 2 Xiaoyue Zhang, 1, 2 Zhenzhou Yang, 1, 2 Zhengjun Guo 1, 2, 4 1 Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China; 2 Chongqing Key Laboratory of Immunotherapy, Chongqing, People's Republic of China; 3 Department of Neuro-Oncology, Chongqing University Cancer Hospital, Chongqing, People's Republic of China; 4 Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, People's Republic of China Correspondence: Zhengjun Guo, Email Purpose: To establish a pragmatic and effective predictive model for monitoring the recovery of radiation enteritis (RE) in cervical cancer patients undergoing concurrent chemoradiotherapy (CCRT). Methods: This study included 105 cervical cancer patients undergoing CCRT. We assessed baseline clinicopathologic characteristics, evaluated the effects of CCRT on circulating immune cells, tumor biomarkers, and inflammatory cytokines, and developed a predictive scoring system, the Immune-Tumor-Score (ITS), using the LASSO-Cox regression model. The model performance of LASSO-Cox and nomogram was compared via ROC curve and calibration curve. Results: The median age of the patients was 55 years, with 53.3% having a normal BMI and 46.7% having positive lymph nodes. Post-CCRT, significant decreases were observed in lymphocyte counts, T-cell subpopulations, and tumor markers (CA125, TPA, SCCA, CYFRA21). The CD4/CD8 ratio and IL10 levels were significantly higher post-CCRT, while inflammation indexes (NLR, ELR) increased, and LMR decreased. The ITS, derived from 11 significant parameters, effectively predicted RE recovery, outperforming a traditional nomogram. Higher ITS scores correlated with shorter RE recovery times, as validated by Kaplan–Meier analyses and ROC curves (AUC = 0.822). Conclusion: The ITS system provides a robust and reliable tool for predicting RE recovery in cervical cancer patients undergoing CCRT, surpassing traditional models in accuracy and reliability. This tool enables better patient management by allowing for timely interventions and personalized treatment strategies. Future research should focus on validating these findings in larger cohorts and integrating additional clinical parameters to enhance the predictive power of the ITS. Keywords: radiation enteritis, cervical cancer, concurrent chemoradiotherapy, inflammatory-tumor score, LASSO-Cox regression model Cervical cancer is a major global health concern, ranking as the fourth most prevalent cancer and the fourth leading cause of cancer-related death in females worldwide. 1 As per the 2020 estimates from the Global Cancer Observatory, China, is expected to account for over 18% of all cervical cancer cases and approximately 17% of estimated global deaths from this disease. 2 Although several Asian countries have reported a decline in cervical cancer incidence, the rate in China has remained relatively stable, even showing a slight increase between 2007 and 2017. 2 Radiotherapy is a cornerstone in the treatment of cervical cancer, especially for patients with advanced disease or those unsuitable for surgery. 3 However, radiation enteritis (RE), a common side effect of pelvic radiotherapy, can significantly impact patients' quality of life, treatment compliance, and overall treatment duration. 4,5 Previous studies have identified the factors that contribute to RE, such as the small bowel radiotherapy and the interruptions during radiotherapy. 5,6 In 2023, Zhou's group highlighted that the anal bulge rating and disease activity index (DAI) score were independent predictors of severe acute RE. 7 While, the factors that contribute to the DAI score, such as weight loss, stool viscosity, and stool bleeding, may not comprehensively represent the spectrum of symptoms and side effects experienced by cervical cancer patients undergoing radiotherapy. 7 This underscores the need for further research to establish more accurate and comprehensive prediction system for RE in cervical cancer patients. 8 To address this issue, our study explored a novel prognostic scoring system, the Inflammatory-Tumor marker Score (ITS). This system leverages peripheral blood count, inflammatory, and tumor markers before and after CCRT to predict the RE recovery status in cervical cancer patients. We propose that the ITS scoring system can enhance clinicians' strategic decision-making and patient management, offering a more accurate prediction -Abstract Truncated-
medicine, general & internal